Literature DB >> 24726166

Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.

Christopher Adlbrecht1, Kurt Huber2, Harmony R Reynolds3, Antonio C Carvalho4, Vladimír Džavík5, Philippe Gabriel Steg6, Li Liu7, Paolo Marino8, Camille A Pearte3, James M Rankin9, Harvey D White10, Gervasio A Lamas10, Judith S Hochman11.   

Abstract

BACKGROUND: The Occluded Artery Trial (OAT) randomized stable patients (n=2201)>24 h (calendar days 3-28) after myocardial infarction (MI) with totally occluded infarct-related arteries (IRA), to percutaneous coronary intervention (PCI) with optimal medical therapy, or optimal medical therapy alone (MED). PCI had no impact on the composite of death, reinfarction, or class IV heart failure over extended follow-up of up to 9 years. We evaluated the impact of early and late reinfarction and definition of MI on subsequent mortality. METHODS AND
RESULTS: Reinfarction was adjudicated according to an adaptation of the 2007 universal definition of MI and the OAT definition (≥2 of the following--symptoms, EKG and biomarkers). Cox regression models were used to analyze the effect of post-randomization reinfarction and baseline variables on time to death. After adjustment for baseline characteristics the 169 (PCI: n=95; MED: n=74) patients who developed reinfarction by the universal definition had a 4.15-fold (95% CI 3.03-5.69, p<0.001) increased risk of death compared to patients without reinfarction. This risk was similar for both treatment groups (interaction p=0.26) and when MI was defined by the stricter OAT criteria. Reinfarctions occurring within 6 months of randomization had similar impact on mortality as reinfarctions occurring later, and the impact of reinfarction due to the same IRA and a different epicardial vessel was similar.
CONCLUSIONS: For stable post-MI patients with totally occluded infarct arteries, reinfarction significantly independently increased the risk of death regardless of the initial management strategy (PCI vs. MED), reinfarction definition, location and early or late occurrence.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Late revascularization; Mortality; Myocardial infarction; Reinfarction

Mesh:

Year:  2014        PMID: 24726166      PMCID: PMC4067126          DOI: 10.1016/j.ijcard.2014.03.149

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  16 in total

1.  Sirolimus-eluting versus uncoated stents in acute myocardial infarction.

Authors:  Christian Spaulding; Patrick Henry; Emmanuel Teiger; Kevin Beatt; Ezio Bramucci; Didier Carrié; Michel S Slama; Bela Merkely; Andrejs Erglis; Massimo Margheri; Olivier Varenne; Ana Cebrian; Hans-Peter Stoll; David B Snead; Christoph Bode
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

2.  Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002.

Authors:  P Buch; S Rasmussen; G H Gislason; J N Rasmussen; L Køber; N Gadsbøll; S Stender; M Madsen; C Torp-Pedersen; S Z Abildstrom
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

3.  Design and methodology of the Occluded Artery Trial (OAT).

Authors:  Judith S Hochman; Gervasio A Lamas; Genell L Knatterud; Christopher E Buller; Vladimir Dzavik; Daniel B Mark; Harmony R Reynolds; Harvey D White
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

4.  Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.

Authors:  M P Hudson; C B Granger; E J Topol; K S Pieper; P W Armstrong; G I Barbash; A D Guerci; A Vahanian; R M Califf; E M Ohman
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

5.  Coronary intervention for persistent occlusion after myocardial infarction.

Authors:  Judith S Hochman; Gervasio A Lamas; Christopher E Buller; Vladimir Dzavik; Harmony R Reynolds; Staci J Abramsky; Sandra Forman; Witold Ruzyllo; Aldo P Maggioni; Harvey White; Zygmunt Sadowski; Antonio C Carvalho; Jamie M Rankin; Jean P Renkin; P Gabriel Steg; Alice M Mascette; George Sopko; Matthias E Pfisterer; Jonathan Leor; Viliam Fridrich; Daniel B Mark; Genell L Knatterud
Journal:  N Engl J Med       Date:  2006-11-14       Impact factor: 91.245

6.  Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.

Authors:  Harvey D White; Harmony R Reynolds; Antonio C Carvalho; Camille A Pearte; Li Liu; C Edwin Martin; Genell L Knatterud; Vladimír Džavík; Mariusz Kruk; Philippe Gabriel Steg; Warren J Cantor; Venu Menon; Gervasio A Lamas; Judith S Hochman
Journal:  Am Heart J       Date:  2012-04       Impact factor: 4.749

7.  Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registry [MIR]).

Authors:  K Dönges; R Schiele; A Gitt; H Wienbergen; S Schneider; R Zahn; R Grube; B Baumgärtel; H G Glunz; J Senges
Journal:  Am J Cardiol       Date:  2001-05-01       Impact factor: 2.778

8.  Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group.

Authors:  R Kornowski; U Goldbourt; M Zion; L Mandelzweig; E Kaplinsky; Y Levo; S Behar
Journal:  Am J Cardiol       Date:  1993-10-15       Impact factor: 2.778

9.  The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction.

Authors:  Steven J Kernis; Kishore J Harjai; Gregg W Stone; Lorelei L Grines; Judith A Boura; Michael W Yerkey; William O'Neill; Cindy L Grines
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  1 in total

1.  [Efficacy of combined ultrasound and microbubble treatment for thrombolysis for rescuing ischemic tissues in rats at different time after thrombosis].

Authors:  Xiaohong Peng; Hairui Li; Xiaoqiang Chen; Jiayuan Zhong; Jian Liu; Shiping Cao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.